The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

Document text

Principal Investigator: Donald E Brown
Organization: UNIVERSITY OF VIRGINIA
Fiscal Year: 2021
Award: $169,903
Funding agency: National Center for Advancing Translational Sciences

Project Summary/Abstract
Healthcare interventions and technologies are appropriate and life-changing for some and clearly unethical or
physiologically futile for others. The band of uncertainty that lies between these two extremes is a common
source of ethical dilemmas in modern healthcare. For about 20% of patients in intensive care units,
interventions may be life-prolonging but they offer little hope of survival outside the acute care setting—a
situation called potentially inappropriate intervention. These situations arise due to multiple factors such as
family demands, poor team collaboration, hierarchies that inhibit honest discussion, and societal norms that
tend to default to aggressive treatments. Healthcare providers recognize these situations as burdensome for
patients who endure high-tech, invasive procedures and treatments but who do not achieve meaningful benefit
from them. As a result, healthcare providers feel they are complicit in wrongdoing--causing unnecessary
suffering, prolonged dying, and lack of truth-telling—otherwise known as moral distress. An intervention to
address this cause of moral distress is a type of ethics consultation called moral distress consultation. This
health system-wide intervention is designed to assist healthcare providers experiencing moral distress to
identify the causes and to design strategies to remedy the causes. Thus, this intervention seeks to improve
patient care by acting on healthcare provider moral distress. A national Moral Distress Consultation
Collaborative, composed of expert moral distress consultants from across the country is poised to more fully
characterize the connection between burdensome interventions and moral distress with the goal of helping
clinicians and families recognize and resolve situations of potentially inappropriate intervention. Consequently,
the specific aims of this study are to 1) generate a taxonomy of barriers and strategies relevant to situations of
potentially inappropriate intervention by harmonizing and evaluating a database from two moral distress
consultation services, 2) evaluate organizational policies and state healthcare laws that play a role in
potentially inappropriate interventions—specifically focusing on policies related to decision making and code
status, and 3) define core competencies for moral distress consultation to promote knowledge and expertise
among the nations moral distress consultants.

Terms: <2019-nCoV vaccine><Address><Area><Arkansas><Bioethics><Biomedical Ethics><COVID-19 vaccine><COVID19 vaccine><Caring><Climacteric><Clinic><Clinical><Clinical Ethics><Clinical Treatment Moab><Code><Coding System><Collaborations><Colorado><Competence><Consultations><Country><Critical Care><Critical Illness><Critically Ill><Curriculum><Data><Data Bases><Databases><Decision Making><Disease><Disorder><Distress><Educational Curriculum><Ethical Issues><Ethicists><Ethics><Ethics Consultants><Ethics Consultation><Ethics in Clinical Practice><Family><Florida><General Taxonomy><Goals><Health><Health Care Providers><Health Personnel><Health Sciences><Health system><Healthcare><Healthcare Delivery><Healthcare Providers><Healthcare worker><Intensive Care Units><Intervention><Intervention Strategies><Knowledge><Laws><Life><Literature><Modernization><Monoclonal Antibodies><Morals><North Carolina><Nurses><Organizational Policy><Outcome Study><Pain><Painful><Patient Care><Patient Care Delivery><Patients><Pattern><Personal Satisfaction><Physicians><Physiologic><Physiological><Play><Policies><Position><Positioning Attribute><Procedures><RNA vaccine><RNA-based vaccine><Research><Research Institute><Research Resources><Resources><Role><SARS-CoV-2 vaccine><SARS-CoV2 vaccine><SARS-coronavirus-2 vaccine><Science><Scientific Advances and Accomplishments><Services><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Source><Structure><Taxonomy><Technology><Training><Translations><Uncertainty><Universities><Virginia><acute care><aggressive breast cancer><aggressive therapy><aggressive treatment><arm><base><burn-out><burnout><clinical practice><corona virus disease 2019 vaccine><coronavirus disease 2019 vaccine><data base><data harmonization><design><designing><doubt><ethical><experience><harmonized data><health care><health care delivery><health care personnel><health care worker><health delivery systems><health practice><health provider><health services delivery><health workforce><healthcare personnel><improved><interventional strategy><lesson plans><life change><mAbs><mRNA vaccine><mRNA-based vaccine><medical personnel><new drug treatments><new drugs><new technology><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel technologies><novel therapeutics><novel therapy><nurse><programs><scientific accomplishments><scientific advances><secondary analysis><social role><treatment provider><unethical><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine for novel coronavirus><well-being><wellbeing>